Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia.
BMC Pediatr. 2013 Jan 25;13:13. doi: 10.1186/1471-2431-13-13.
There is little reliable information on the prevalence of fetal alcohol spectrum disorders (FASD) in Australia and no coordinated national approach to facilitate case detection. The aim of this study was to identify health professionals' perceptions about screening for FASD in Australia.
A modified Delphi process was used to assess perceptions of the need for, and the process of, screening for FASD in Australia. We recruited a panel of 130 Australian health professionals with experience or expertise in FASD screening or diagnosis. A systematic review of the literature was used to develop Likert statements on screening coverage, components and assessment methods which were administered using an online survey over two survey rounds.
Of the panel members surveyed, 95 (73%) responded to the questions on screening in the first survey round and, of these, 81 (85%) responded to the second round. Following two rounds there was consensus agreement on the need for targeted screening at birth (76%) and in childhood (84%). Participants did not reach consensus agreement on the need for universal screening at birth (55%) or in childhood (40%). Support for targeted screening was linked to perceived constraints on service provision and the need to examine the performance, costs and benefits of screening.For targeted screening of high risk groups, we found highest agreement for siblings of known cases of FASD (96%) and children of mothers attending alcohol treatment services (93%). Participants agreed that screening for FASD primarily requires assessment of prenatal alcohol exposure at birth (86%) and in childhood (88%), and that a checklist is needed to identify the components of screening and criteria for referral at birth (84%) and in childhood (90%).
There is an agreed need for targeted but not universal screening for FASD in Australia, and sufficient consensus among health professionals to warrant development and evaluation of standardised methods for targeted screening and referral in the Australian context. Participants emphasised the need for locally-appropriate, evidence-based approaches to facilitate case detection, and the importance of ensuring that screening and referral programs are supported by adequate diagnostic and management capacity.
澳大利亚关于胎儿酒精谱系障碍(FASD)的流行情况的可靠信息很少,也没有协调一致的国家方法来促进病例发现。本研究的目的是确定澳大利亚卫生专业人员对 FASD 筛查的看法。
采用改良 Delphi 法评估澳大利亚 FASD 筛查的必要性和筛查过程。我们招募了 130 名具有 FASD 筛查或诊断经验或专业知识的澳大利亚卫生专业人员组成专家组。通过系统综述文献,制定了关于筛查范围、组成部分和评估方法的李克特量表陈述,这些陈述通过两轮在线调查进行了管理。
在接受调查的专家组中,95 人(73%)对第一轮调查中的筛查问题作出了回应,其中 81 人(85%)对第二轮调查作出了回应。经过两轮调查,专家组就出生时(76%)和儿童时期(84%)需要有针对性的筛查达成了共识。对于出生时(55%)或儿童时期(40%)是否需要进行普遍筛查,参与者未达成共识。对有针对性筛查的支持与服务提供的限制以及需要检查筛查的性能、成本和效益有关。对于高风险群体的有针对性筛查,我们发现已知 FASD 病例的兄弟姐妹(96%)和母亲参加酒精治疗服务的儿童(93%)的支持率最高。参与者一致认为,FASD 的筛查主要需要评估出生时(86%)和儿童时期(88%)的产前酒精暴露,并需要制定检查表以确定筛查的组成部分和出生时(84%)和儿童时期(90%)的转诊标准。
澳大利亚有针对性而非普遍筛查 FASD 的需求得到了认可,并且卫生专业人员之间有足够的共识,有理由在澳大利亚背景下制定和评估针对目标人群的筛查和转诊的标准化方法。参与者强调需要采用适合当地情况的、基于证据的方法来促进病例发现,并确保筛查和转诊计划得到充分的诊断和管理能力的支持。